There are certain dietary requirements that support the effectiveness of this drug, and Trifecta is here to support you in your health journey with meals that closely meet that dietary criteria
Clinical trials lasting one year show that semaglutide produces about 16 percent average weight loss, while tirzepatide at 15 mg weekly reaches around 22.5 percent
Clostridium butyricum produces the postbiotic butyrate which stimulates GLP-1. Bifidobacterium infantis produces the postbiotic acetate, and interacts with Akkermansia and Butyricum to promote an ecosystem in the gut that naturally boosts GLP-1
Management: Small, bland meals
For deeper comparison context, see our companion guides on semaglutide and tirzepatide
The cardioprotective effects of GLP-1RAs include anti-inflammatory actions, reduction of myocardial ischemia injury, modifications in the synthesis and secretion of lipids, and improvement of endothelial dysfunction (109)